Androgen deficiency in the aging male;Déficit androgénique lié à l'age

Andrologie

Volumn 11, Issue 4, 2001, Pages 231-239

  Lejeune, Hervé ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Androgen replacement therapy; Andropause; Bioavailable; Testosterone

Indexed keywords

ANDROGEN; CHORIONIC GONADOTROPIN; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; BONE MASS; CELL FUNCTION; CLINICAL PRACTICE; DISEASE COURSE; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; LEYDIG CELL; LIBIDO; LONGITUDINAL STUDY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MUSCLE MASS; MUSCLE STRENGTH; ONSET AGE; PENIS ERECTION; RELIABILITY; SYMPTOM; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL; WELLBEING;

EID: 18244412176     PISSN: 11662654     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03034636     Document Type: Article

References (54)

1. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men
2. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue
3. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls
4. Loss of circadian rythmicity in blood testosterone levels with aging in normal men
5. Effects of androgen on sexual behavior in hypogonadal men
6. Hormonal changes and sexual function in aging men
7. Radioimmunoassay of testosterone not bound to sex-steroid-binding protein in plasma
8. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men
9. Leydig cell function in normal men: Effect of age, life-style, residence, diet and activity
10. Prospective study of sex hormone levels and risk of prostate cancer
11. Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis
12. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging
13. Reproductive hormones in aging male. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone
14. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: A longitudinal study
15. A new 'aging males' symptoms' rating scale
16. Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men
17. Quantification of human Sertoli cell population: Its distribution, relation to germ cell number, and age-related decline
18. Endocrine and metabolic aspect including treatment
19. The nature of androgen action on male sexuality: A combined laboratory-self-report study on hypogonadal men
20. Serum 5a-dihydrotestosterone and testosterone, changes with age in man
21. Androgen treatment of middle-aged, obese men: Effects on metabolism and adipose tissues
22. Familial effects on plasma sex-steroid content in man: Testosterone, estradiol and sex hormone-binding-globulin
23. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
24. Validation of a screening questionnaire for androgen deficiency in aging males
25. Age-related changes in the feedback regulation of gonadotrophin secretion by sex steroids in men
26. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men
27. Androgens, Behaviour and norcturnal erection in hypogonadal men: The effects of varying the replacement dose
28. Age changes ans sex differences in serum Dehydroepiandrosterone sulfate concentrations throughout Adulthood
29. Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males
30. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin
31. Transport of steroid hormones: Interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma
32. Report of national institute on aging advisory panel on testosterone replacement in men
33. An Extraordinary inaccurate assay for free testosterone is still with us
34. Further studies on Leydig cell function in old age
35. A case of authenticated fertility in a man of 94
36. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial
37. The influence of aging on plasma sex hormone in men: The telecom study
38. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men
39. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age
40. Effect of testosterone treatment on bone mineral density in men over 65 years of age
41. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
42. Effects of testosterone supplementation in the aging male
43. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men
44. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate
45. Decreased serum inhibin levels in normal elderly men: Evidence for a decline in Sertoli cell function with aging
46. Attenuated release of biologically active luteinizing hormone in healthy aging men
47. Influence of antiopioids on luteinizing hormone pulsatility in aging men
48. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males
49. Testosterone secretion and metabolism in male senescence
50. Effects of aging and illness on the pituitary testicular axis in men: Qualitative as well as quantitative changes in luteinizing hormone
51. The gonadotropin-suppressive activity of androgen is increased in eldrely men
52. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: Evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion
53. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens and gonadotropins in normal adult men